IL2 and neoplasm: Tumor volumes in the THT plus i.t. IL-2 treated group were significantly reduced compared to controls 2 days following THT treatment, significantly reduced compared to the i.t. IL-2 only group 6 days post-NIR exposure, and significantly reduced compared to THT alone 8 days post-NIR exposure.